Validation of a Novel Cerebellar-striatal Satiety Circuit in Humans
1 other identifier
interventional
150
1 country
2
Brief Summary
This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study satiety in healthy individuals. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study, the investigators will be stimulating the brain to learn more about the role of the cerebellum in satiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2023
CompletedFirst Posted
Study publicly available on registry
October 27, 2023
CompletedStudy Start
First participant enrolled
December 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2029
December 5, 2025
December 1, 2025
4.7 years
October 19, 2023
December 1, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in BOLD response in the cerebellum
Change in functional activation of the cerebellum will be assessed before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.
30 minutes pre-TMS and 30 minutes post-TMS, at each of two main study visits (fed, fasted)
Change in BOLD response in the ventral striatum
Change in functional activation of the ventral striatum will be assessed before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.
30 minutes pre-TMS and 30 minutes post-TMS, at each of two main study visits (fed, fasted)
Change in food reward valuation
Change in food reward valuation of high-calorie foods will be assessed using the Willingness to Pay task, measured before (pre-TMS) and after (post-rTMS) rTMS stimulation, measured separately at the fed visit and at the fasted visit.
up to 60 minutes pre-TMS and up to 60 minutes post-TMS, at each of two main study visits (fed, fasted)
Ad libitum snack food intake
Change in total caloric intake during the ad libitum snack food session will be assessed at the baseline visit and after (post-rTMS) rTMS stimulation, the latter measured separately at the fed visit and at the fasted visit.
baseline, up to 60 minutes post-TMS at each of two main study visits (fed, fasted)
Study Arms (2)
Active cerebellar rTMS
ACTIVE COMPARATORCerebellar targeted iTBS
Sham cerebellar rTMS
SHAM COMPARATORCerebellar targeted sham iTBS
Interventions
rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry. Intermittent theta burst stimulation (iTBS) consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses (82), will be applied to the target. Cerebellar stimulation will be applied to the targets at 100% of aMT or 35% maximal stimulator output, whichever is higher.
rTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces electrical current in neurons and allows for modulation of neural circuitry. Intermittent theta burst stimulation (iTBS) consisting of 2 s trains of 3 pulses at 50 Hz, repeated at 5 Hz, every 10s for a total of 600 pulses (82), will be applied to the target. Cerebellar stimulation will be applied to the targets at 100% of aMT or 35% maximal stimulator output, whichever is higher. Sham is achieved by using a coil with a magnetic shield preventing magnetic field from reaching the head.
Eligibility Criteria
You may qualify if:
- Healthy individuals aged 18 to 65
- BMI of 20-35.0 kg/m2
- Normal or corrected-to-normal vision
- Good general health
- Ability to understand and willingness to sign written informed consent document
You may not qualify if:
- Current and/or past medical conditions
- Current and/or past eating disorder
- On a restricted diet and/or taking weight loss medication(s)
- History of bariatric surgery
- Weight fluctuation \>3% in past 3 months
- Recent history of illicit recreational drug abuse
- Current nicotine use
- Intellectual disability
- Conditions that might result in increased risks of side effects or complications from TMS or MRI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- Mclean Hospitalcollaborator
- Beth Israel Deaconess Medical Centercollaborator
Study Sites (2)
McLean Hospital
Belmont, Massachusetts, 02478, United States
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Holsen, PhD
Brigham and Women's Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Psychiatry
Study Record Dates
First Submitted
October 19, 2023
First Posted
October 27, 2023
Study Start
December 5, 2024
Primary Completion (Estimated)
August 1, 2029
Study Completion (Estimated)
August 1, 2029
Last Updated
December 5, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
Deidentified participant data will be shared with NIMH Data Repository (NDA).